G6PC3缺陷人类中性粒细胞的代谢异常导致严重功能缺陷
本文报道一名由G6PC3复合杂合突变(已知错义突变c.758G>A[p.R235H]及新错义突变c.325G>A[p.G109S])所致的严重先天性中性粒细胞减少症4型(SCN-4)患儿。G-CSF治疗纠正中性粒细胞减少后,患儿中性粒细胞随机和定向迁移严重受损,杀菌活性下降,超氧化物生成小于对照值的25%;代谢组学显示早期糖酵解、磷酸己糖旁路和总腺苷酸池严重受损。果糖补充初步实验可逆转代谢谱但未能持久改善功能。
要点
- G6PC3复合杂合突变可致SCN-4,表现为中性粒细胞减少、功能障碍及反复细菌感染。
- 患儿中性粒细胞迁移、吞噬及杀菌功能严重受损,超氧化物生成小于对照值的25%。
- 代谢缺陷涉及早期糖酵解、磷酸己糖旁路和总腺苷酸池,是功能缺陷的基础。
核心结论
- G6PC3缺陷所致代谢缺陷可解释中性粒细胞多种功能缺陷,并构成主要感染风险。
研究设计与样本
- 病例报告:一名SCN-4患儿,经G-CSF治疗后对其中性粒细胞进行功能与代谢评估。
主要发现
- 患儿中性粒细胞随机和定向迁移严重减弱,伴CD11b表达和F-actin组装缺陷。
- 细菌/中性粒细胞比例大于1:1时杀菌活性下降,与摄取减弱相关。
- 超氧化物阴离子生成小于对照值的25%,但phox蛋白定量正常。
- 稳态及稳定同位素示踪(U-13C-葡萄糖、13C,15N-谷氨酰胺、U-13C-果糖)显示早期糖酵解、磷酸己糖旁路和总腺苷酸池严重受损。
- 果糖补充初步实验可逆转代谢谱,但未持久至功能改善。
临床怎么用
- 对SCN-4患者应评估中性粒细胞迁移、吞噬、杀菌及超氧化物生成等功能缺陷。
- G-CSF可纠正中性粒细胞减少,从而允许开展详细中性粒细胞功能评估。
局限性
- 为单例病例报告,代谢逆转实验仅为初步且未持久改善功能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Severe congenital neutropenia type 4 (SCN-4) is an autosomal recessive condition in which mutations in the G6PC3 gene encoding for the catalytic 3 subunit of glucose-6-phosphatase-β result in neutropenia, neutrophil dysfunction, and other syndromic features. We report a child with SCN-4 caused by compound heterozygous mutations in G6PC3, a previously identified missense mutation in exon 6 (c.758G>A[p.R235H]), and a novel missense mutation in exon 2 (c.325G>A[p.G109S]). The patient had recurrent bacterial infections, inflammatory bowel disease, neutropenia, and intermittent thrombocytopenia. Administration of granulocyte colony-stimulating factor (G-CSF) resolved the neutropenia and allowed for detailed evaluation of human neutrophil function. Random and directed migration by the patient's neutrophils was severely diminished. Associated with this were defects in CD11b expression and F-actin assembly. Bactericidal activity at bacteria/neutrophil ratios >1:1 was also diminished and was associated with attenuated ingestion. Superoxide anion generation was <25% of control values, but phox proteins appeared quantitatively normal. Extensive metabolomics analysis at steady state and upon incubation with stable isotope-labeled tracers (U-13C-glucose, 13C,15N-glutamine, and U-13C-fructose) demonstrated dramatic impairments in early glycolysis (hexose phosphate levels), hexosemonophosphate shunt (required for the generation of the NADPH), and the total adenylate pool, which could explain the dramatic cell dysfunction displayed by the patient's neutrophils. Preliminary experiments with fructose supplementation to bypass the enzyme block demonstrated that the metabolic profile could be reversed, but was not sustained long enough for functional improvement. In human deficiency of G6PC3, metabolic defects resulting from the enzyme deficiency account for diverse neutrophil functional defects and present a major risk of infection.
引用
- McKinney C, Ellison M, Briones NJ, et al. Metabolic abnormalities in G6PC3-deficient human neutrophils result in severe functional defects. Blood Adv. 2020. PMID: 33259599. doi:10.1182/bloodadvances.2020002225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。